Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

435 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Stable Silapyramidanes.
Imagawa T, Giarrana L, Andrada DM, Morgenstern B, Nakamoto M, Scheschkewitz D. Imagawa T, et al. J Am Chem Soc. 2023 Mar 1;145(8):4757-4764. doi: 10.1021/jacs.2c13530. Epub 2023 Feb 14. J Am Chem Soc. 2023. PMID: 36787446
Usefulness of endoscopic ultrasound-guided transhepatic biliary drainage with a 22-gauge fine-needle aspiration needle and 0.018-inch guidewire in the procedure's induction phase.
Yane K, Yoshida M, Imagawa T, Morita K, Ihara H, Hanada K, Hirokawa S, Tomita Y, Minagawa T, Okagawa Y, Sumiyoshi T, Hirayama M, Kondo H. Yane K, et al. Among authors: imagawa t. DEN Open. 2023 Oct 10;4(1):e297. doi: 10.1002/deo2.297. eCollection 2024 Apr. DEN Open. 2023. PMID: 37822965 Free PMC article.
Clinical factors associated with acute abdominal symptoms induced by gastric anisakiasis: a multicenter retrospective cohort study.
Okagawa Y, Sumiyoshi T, Imagawa T, Sakano H, Tamura F, Arihara Y, Kanari Y, Sakurada A, Oiwa S, Jin T, Tomita Y, Minami S, Hisai H, Muramatsu H, Katsuki S, Maeda M, Kondo H. Okagawa Y, et al. Among authors: imagawa t. BMC Gastroenterol. 2023 Jul 18;23(1):243. doi: 10.1186/s12876-023-02880-7. BMC Gastroenterol. 2023. PMID: 37464307 Free PMC article.
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial.
Ramanan AV, Quartier P, Okamoto N, Foeldvari I, Spindler A, Fingerhutová Š, Antón J, Wang Z, Meszaros G, Araújo J, Liao R, Keller S, Brunner HI, Ruperto N; JUVE-BASIS investigators; Paediatric Rheumatology International Trials Organisation. Ramanan AV, et al. Lancet. 2023 Aug 12;402(10401):555-570. doi: 10.1016/S0140-6736(23)00921-2. Epub 2023 Jul 6. Lancet. 2023. PMID: 37423231 Clinical Trial.
435 results